Point Capital Inc (PTCI) 1.0000 $PTCI
NOTICE TO AECOM CURRENT AND FORMER EMPLOYEES: Zamansky LLC Investigates the AECOM Retirement & Savings Plan for Possible ERISA Violations
BusinessWire - Fri Sep 16, 4:01PM CDT
Zamansky LLC announces that it has commenced an investigation of AECOM (NYSE:ACM) on behalf of its current and former employees over the AECOM Retirement & Savings Plan (the "Plan"
for potential violations of the federal Employee Retirement Income Security Act ("ERISA". ERISA imposes fiduciary duties to prudently manage and invest plan assets. We are investigating whether these duties were violated by the continued offering of the AECOM stock, or ACM, as an investment option for employees under the Plan.
ACM: 27.91 (-0.39)
Axcella to Present at Wedbush PacGrow Healthcare Conference
BusinessWire - Tue Aug 09, 6:00AM CDT
Axcella Health Inc., a biotechnology company pioneering transformative medicines for patients with conditions where disrupted amino acid biology plays a critical role, announced today that Robert Connelly, President and Chief Executive Officer, will present a company overview at the Wedbush PacGrow Healthcare Conference in New York, N.Y. The presentation will take place August 16, 2016, at 3:05 p.m. EDT.
Axcella to Present at Jefferies 2016 Healthcare Conference
BusinessWire - Wed Jun 08, 6:00AM CDT
Axcella Health Inc., a biotechnology company pioneering transformative medicines for patients with conditions where disrupted amino acid biology plays a critical role, announced today that Robert Connelly, President and Chief Executive Officer, will present a company overview at the Jefferies 2016 Healthcare Conference in New York, N.Y. The presentation will take place June 9, 2016, at 9 a.m. EDT.
CCRE Achieves Status As The Nation's Fastest Growing Commercial Real Estate Loan Servicer With A $50 Billion Servicing Portfolio
PR Newswire - Fri Dec 18, 12:28PM CST
CCRE, a fully-integrated commercial real estate finance company, today announced that it has surpassed $50 billion in total commercial and multifamily loans serviced for its clients. The firm's commercial real estate servicing portfolio has grown at a rate of 47% through Q3 this year and stands as the fastest growing commercial loan servicing portfolio since the beginning of 2015 based on the most recent data provided by the MBA. Through its Berkeley Point Capital subsidiary, the firm services a diverse portfolio comprising approximately 2,800 commercial real estate loans throughout the United States.
Intertain Group Limited Statement on Spruce Point Capital Report
Marketwired - Fri Dec 18, 6:01AM CST
The Intertain Group Limited ("Intertain" or the "Company" (TSX: IT) today issued a statement to address what it considers to be a misleading and self-serving report that was published on December 17, 2015 by a self-identified short-seller of the Company's common shares, Spruce Point Capital Management LLC (the "Fund". Intertain stands behind the integrity of the Company's public disclosures.
IT.TO: 11.23 (+0.18)
IRSA Inversiones y Representaciones S.A. Material Fact
PR Newswire - Fri Nov 20, 9:02AM CST
IRSA Inversiones y Representaciones S.A. (NYSE: IRS; MERVAL: IRSA), the leading real estate company in Argentina, today issued a statement in response to what it considers to be a misleading, unprincipled report issued on November 19, 2015 by Spruce Point Capital Management (the "Fund" and to unusually high trading volume in its stock shortly after publication of the Spruce Point report.
IRS: 18.25 (-0.03)
Cresud S.A.C.I.F. y A. Material Fact
PR Newswire - Fri Nov 20, 8:59AM CST
Cresud S.A.C.I.F. y A. (NASDAQ: CRESY, MERVAL: CRES), today issued a statement in response to what it considers to be a misleading, unprincipled report issued on November 19, 2015 by Spruce Point Capital Management (the "Fund" and to unusually high trading volume in its stock shortly after publication of the Spruce Point report.
CRESY: 16.93 (-0.23), LND: 3.35 (unch)
Gurnet Point Capital Launches New Drug Development Company, Boston Pharmaceuticals, with $600 Million Commitment
BusinessWire - Thu Nov 19, 7:30AM CST
Gurnet Point Capital, an investment firm focused on the healthcare and life sciences sectors that was founded by Ernesto Bertarelli and is led by Christopher A. Viehbacher, today announced the creation of Boston Pharmaceuticals, a fully-integrated drug development company that will offer an innovative alternative model for drug development and commercialization.
Skillsoft Closes $150 Million Credit Facility
BusinessWire - Fri Oct 30, 12:15PM CDT
Skillsoft announced today that it has entered into a $150 million accounts receivable Credit Facility provided by Sound Point Capital Management, LP and Morgan Stanley Senior Funding, Inc.
Christopher A. Viehbacher Joins Pronutria Biosciences' Board of Directors
BusinessWire - Thu Oct 15, 6:30AM CDT
Pronutria Biosciences Inc., a biotechnology company pioneering a new therapeutic modality to mediate amino acid biology, today announced that Christopher A. Viehbacher, Managing Partner, Gurnet Point Capital, will join Pronutria's Board of Directors. In addition, Gurnet Point Capital has made an investment in Pronutria, the fund's first announced investment, completing Pronutria's Series C financing. The terms of the investment were not disclosed.
Fitch Publishes Servicer Report on Berkeley Point Capital LLC
BusinessWire - Thu Sep 03, 2:11PM CDT
Fitch Ratings has published a servicer report on Berkeley Point Capital LLC. This report provides an overview of the company's servicing operations and a discussion of the areas evaluated by Fitch.
Point Capital Quarterly Update
GlobeNewswire - Thu Sep 03, 8:00AM CDT
Point Capital Inc. (OTCQB
TCI),
Caesarstone Issues Statement
BusinessWire - Thu Aug 20, 7:45AM CDT
Caesarstone Sdot-Yam Ltd. (NASDAQ:CSTE), a manufacturer of high quality engineered quartz surfaces, today issued a statement to address what it considers to be a generally misleading report that includes inaccuracies and tendentiously false conclusions. The report was published on August 19, 2015 by Spruce Point Capital Management, a self-identified short-seller in the Company's stock, which indicates that due to its short position in Caesarstone's stocks it shall realize significant gains in the event that the price of Caesarstone's stocks declines.
CSTE: 38.35 (-1.14)
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Securities Laws by CaesarStone Sdot-Yam Ltd.
BusinessWire - Wed Aug 19, 2:35PM CDT
Levi & Korsinsky has commenced an investigation on behalf of shareholders of CaesarStone Sdot-Yam Ltd. (NASDAQGS:CSTE) concerning whether CaesarStone and certain of its officers and/or directors have violated federal securities laws.
CSTE: 38.35 (-1.14)
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against CaesarStone Sdot-Yam Ltd.
BusinessWire - Wed Aug 19, 1:31PM CDT
The Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of CaesarStone Sdot-Yam Ltd. (NASDAQ: CSTE) resulting from allegations that CaesarStone may have issued materially misleading business information to the investing public.
CSTE: 38.35 (-1.14)
Fitch Affirms Berkeley Point's Servicer Ratings
BusinessWire - Thu Jul 30, 4:26PM CDT
Fitch Ratings affirms the commercial real estate servicer ratings for Berkeley Point Capital LLC (BPC), as follows:
Graham Goldsmith and Stone Point Capital Form Cross Ocean Partners and Acquire European Special Situations Business From Capula Investment Management
Marketwired - Tue Jul 07, 10:10AM CDT
Graham Goldsmith and Stone Point Capital announced today the formation of Cross Ocean Partners, an asset management platform that will focus on stressed and distressed credit investment opportunities. Goldsmith, the former Head of Global Credit and Special Situations at Bank of America Merrill Lynch ("BAML", will be the company's Chief Executive Officer and Co-Chief Investment Officer. Funds managed by Stone Point together with Goldsmith and other members of management have committed $240 million to Cross Ocean.
When Interest Rates Rise: How High Net Worth Investors Can Prepare for the Inevitable
JCN Newswire - Fri Jun 05, 3:59PM CDT
"We are at the end of a 30-year secular decline in interest rates. While the current global interest rate environment remains benign, the long-term trend is going to rise. Hence, we are at an inflection point in interest rates. Managers will have to change their investment approach to adjust for this inevitable reversal," says Jeff Bates, Managing Partner, Kings Point Capital Management.
Broadstone Real Estate and Stone Point Capital Partner for Growth
PR Newswire - Mon Jun 01, 10:38AM CDT
Broadstone Real Estate, LLC (BRE) today announced that it has signed a definitive agreement to partner with Stone Point Capital to expand and grow BRE's operating platform as a manager of alternative real estate investments. Stone Point Capital, through its Trident VI fund, will purchase an equity interest in BRE. Proceeds from the investment will be primarily used to invest in the two private real estate investment offerings currently managed by BRE, Broadstone Net Lease (BNL) and Broadtree Homes (BTH). As a result of the transaction, BRE will invest a significant amount of new capital into BNL and BTH. These investments by BRE will substantially increase management's commitment to both investment offerings.
NOTICE TO AECOM CURRENT AND FORMER EMPLOYEES: Zamansky LLC Investigates the AECOM Retirement & Savings Plan for Possible ERISA Violations
BusinessWire - Fri Sep 16, 4:01PM CDT
Zamansky LLC announces that it has commenced an investigation of AECOM (NYSE:ACM) on behalf of its current and former employees over the AECOM Retirement & Savings Plan (the "Plan"
for potential violations of the federal Employee Retirement Income Security Act ("ERISA". ERISA imposes fiduciary duties to prudently manage and invest plan assets. We are investigating whether these duties were violated by the continued offering of the AECOM stock, or ACM, as an investment option for employees under the Plan. ACM: 27.91 (-0.39)
Axcella to Present at Wedbush PacGrow Healthcare Conference
BusinessWire - Tue Aug 09, 6:00AM CDT
Axcella Health Inc., a biotechnology company pioneering transformative medicines for patients with conditions where disrupted amino acid biology plays a critical role, announced today that Robert Connelly, President and Chief Executive Officer, will present a company overview at the Wedbush PacGrow Healthcare Conference in New York, N.Y. The presentation will take place August 16, 2016, at 3:05 p.m. EDT.
Axcella to Present at Jefferies 2016 Healthcare Conference
BusinessWire - Wed Jun 08, 6:00AM CDT
Axcella Health Inc., a biotechnology company pioneering transformative medicines for patients with conditions where disrupted amino acid biology plays a critical role, announced today that Robert Connelly, President and Chief Executive Officer, will present a company overview at the Jefferies 2016 Healthcare Conference in New York, N.Y. The presentation will take place June 9, 2016, at 9 a.m. EDT.
CCRE Achieves Status As The Nation's Fastest Growing Commercial Real Estate Loan Servicer With A $50 Billion Servicing Portfolio
PR Newswire - Fri Dec 18, 12:28PM CST
CCRE, a fully-integrated commercial real estate finance company, today announced that it has surpassed $50 billion in total commercial and multifamily loans serviced for its clients. The firm's commercial real estate servicing portfolio has grown at a rate of 47% through Q3 this year and stands as the fastest growing commercial loan servicing portfolio since the beginning of 2015 based on the most recent data provided by the MBA. Through its Berkeley Point Capital subsidiary, the firm services a diverse portfolio comprising approximately 2,800 commercial real estate loans throughout the United States.
Intertain Group Limited Statement on Spruce Point Capital Report
Marketwired - Fri Dec 18, 6:01AM CST
The Intertain Group Limited ("Intertain" or the "Company"
(TSX: IT) today issued a statement to address what it considers to be a misleading and self-serving report that was published on December 17, 2015 by a self-identified short-seller of the Company's common shares, Spruce Point Capital Management LLC (the "Fund". Intertain stands behind the integrity of the Company's public disclosures. IT.TO: 11.23 (+0.18)
IRSA Inversiones y Representaciones S.A. Material Fact
PR Newswire - Fri Nov 20, 9:02AM CST
IRSA Inversiones y Representaciones S.A. (NYSE: IRS; MERVAL: IRSA), the leading real estate company in Argentina, today issued a statement in response to what it considers to be a misleading, unprincipled report issued on November 19, 2015 by Spruce Point Capital Management (the "Fund"
and to unusually high trading volume in its stock shortly after publication of the Spruce Point report. IRS: 18.25 (-0.03)
Cresud S.A.C.I.F. y A. Material Fact
PR Newswire - Fri Nov 20, 8:59AM CST
Cresud S.A.C.I.F. y A. (NASDAQ: CRESY, MERVAL: CRES), today issued a statement in response to what it considers to be a misleading, unprincipled report issued on November 19, 2015 by Spruce Point Capital Management (the "Fund"
and to unusually high trading volume in its stock shortly after publication of the Spruce Point report. CRESY: 16.93 (-0.23), LND: 3.35 (unch)
Gurnet Point Capital Launches New Drug Development Company, Boston Pharmaceuticals, with $600 Million Commitment
BusinessWire - Thu Nov 19, 7:30AM CST
Gurnet Point Capital, an investment firm focused on the healthcare and life sciences sectors that was founded by Ernesto Bertarelli and is led by Christopher A. Viehbacher, today announced the creation of Boston Pharmaceuticals, a fully-integrated drug development company that will offer an innovative alternative model for drug development and commercialization.
Skillsoft Closes $150 Million Credit Facility
BusinessWire - Fri Oct 30, 12:15PM CDT
Skillsoft announced today that it has entered into a $150 million accounts receivable Credit Facility provided by Sound Point Capital Management, LP and Morgan Stanley Senior Funding, Inc.
Christopher A. Viehbacher Joins Pronutria Biosciences' Board of Directors
BusinessWire - Thu Oct 15, 6:30AM CDT
Pronutria Biosciences Inc., a biotechnology company pioneering a new therapeutic modality to mediate amino acid biology, today announced that Christopher A. Viehbacher, Managing Partner, Gurnet Point Capital, will join Pronutria's Board of Directors. In addition, Gurnet Point Capital has made an investment in Pronutria, the fund's first announced investment, completing Pronutria's Series C financing. The terms of the investment were not disclosed.
Fitch Publishes Servicer Report on Berkeley Point Capital LLC
BusinessWire - Thu Sep 03, 2:11PM CDT
Fitch Ratings has published a servicer report on Berkeley Point Capital LLC. This report provides an overview of the company's servicing operations and a discussion of the areas evaluated by Fitch.
Point Capital Quarterly Update
GlobeNewswire - Thu Sep 03, 8:00AM CDT
Point Capital Inc. (OTCQB
TCI), Caesarstone Issues Statement
BusinessWire - Thu Aug 20, 7:45AM CDT
Caesarstone Sdot-Yam Ltd. (NASDAQ:CSTE), a manufacturer of high quality engineered quartz surfaces, today issued a statement to address what it considers to be a generally misleading report that includes inaccuracies and tendentiously false conclusions. The report was published on August 19, 2015 by Spruce Point Capital Management, a self-identified short-seller in the Company's stock, which indicates that due to its short position in Caesarstone's stocks it shall realize significant gains in the event that the price of Caesarstone's stocks declines.
CSTE: 38.35 (-1.14)
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Securities Laws by CaesarStone Sdot-Yam Ltd.
BusinessWire - Wed Aug 19, 2:35PM CDT
Levi & Korsinsky has commenced an investigation on behalf of shareholders of CaesarStone Sdot-Yam Ltd. (NASDAQGS:CSTE) concerning whether CaesarStone and certain of its officers and/or directors have violated federal securities laws.
CSTE: 38.35 (-1.14)
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against CaesarStone Sdot-Yam Ltd.
BusinessWire - Wed Aug 19, 1:31PM CDT
The Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of CaesarStone Sdot-Yam Ltd. (NASDAQ: CSTE) resulting from allegations that CaesarStone may have issued materially misleading business information to the investing public.
CSTE: 38.35 (-1.14)
Fitch Affirms Berkeley Point's Servicer Ratings
BusinessWire - Thu Jul 30, 4:26PM CDT
Fitch Ratings affirms the commercial real estate servicer ratings for Berkeley Point Capital LLC (BPC), as follows:
Graham Goldsmith and Stone Point Capital Form Cross Ocean Partners and Acquire European Special Situations Business From Capula Investment Management
Marketwired - Tue Jul 07, 10:10AM CDT
Graham Goldsmith and Stone Point Capital announced today the formation of Cross Ocean Partners, an asset management platform that will focus on stressed and distressed credit investment opportunities. Goldsmith, the former Head of Global Credit and Special Situations at Bank of America Merrill Lynch ("BAML"
, will be the company's Chief Executive Officer and Co-Chief Investment Officer. Funds managed by Stone Point together with Goldsmith and other members of management have committed $240 million to Cross Ocean. When Interest Rates Rise: How High Net Worth Investors Can Prepare for the Inevitable
JCN Newswire - Fri Jun 05, 3:59PM CDT
"We are at the end of a 30-year secular decline in interest rates. While the current global interest rate environment remains benign, the long-term trend is going to rise. Hence, we are at an inflection point in interest rates. Managers will have to change their investment approach to adjust for this inevitable reversal," says Jeff Bates, Managing Partner, Kings Point Capital Management.
Broadstone Real Estate and Stone Point Capital Partner for Growth
PR Newswire - Mon Jun 01, 10:38AM CDT
Broadstone Real Estate, LLC (BRE) today announced that it has signed a definitive agreement to partner with Stone Point Capital to expand and grow BRE's operating platform as a manager of alternative real estate investments. Stone Point Capital, through its Trident VI fund, will purchase an equity interest in BRE. Proceeds from the investment will be primarily used to invest in the two private real estate investment offerings currently managed by BRE, Broadstone Net Lease (BNL) and Broadtree Homes (BTH). As a result of the transaction, BRE will invest a significant amount of new capital into BNL and BTH. These investments by BRE will substantially increase management's commitment to both investment offerings.
